IPO
Galapagos NV presents financial results and highlights the key events for the first quarter of 2019.
Conference call to be held today, 25 April 2019, 3:00pm CET/2:00pm BST
Preparations for Upcoming Clinical Data in the MERECA and GIST Studies and First Patient Treated in the ILIAD Study
Assertio Therapeutics, Inc. announced that it will release first quarter 2019 financial results on Wednesday, May 8, 2019, after the close of markets.
Pharnext SA announced its financial results for the fiscal year ended December 31st, 2018.
MDxHealth SA, a commercial-stage innovative molecular diagnostics company, provided a business update for the first quarter ended March 31, 2019.
Retrophin, Inc. announced it will report first quarter 2019 financial results on Tuesday, May 7, 2019 after the close of the U.S. financial markets.
Soligenix, Inc. issued an update letter from its President and Chief Executive Officer, Dr. Christopher J. Schaber.
Eur 140 m bridge loan was drawn to secure evotec’s value chain expansion by successful acquisition of aptuit in august 2017
312 shareholders attended, representing 60% of the issued share capital
PRESS RELEASES